Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Potentiation of β-lactam antibiotics and β-lactam/β-lactamase inhibitor combinations against multidrug and extensively drug-resistant Pseudomonas aeruginosa using non-ribosomal tobramycin-cyclam conjugates

Potentiation of β-lactam antibiotics and β-lactam/β-lactamase inhibitor combinations against multidrug and extensively drug-resistant Pseudomonas aeruginosa using non-ribosomal tobramycin-cyclam conjugates

US Patent 11998560 · Granted Jun 4, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for controlling an SCR catalytic converter2022
Glycosylated antitumor ether lipids as novel cancer stem cell cytotoxic agents2022
Method for controlling an SCR catalytic converter2021
Di- and tri-cationic glycosylated antitumor ether lipids, L-gucosylated gaels an2020
Di- and tri-cationic glycosylated antitumor ether lipids, L-gucosylated gaels an2020
Method for operating an SCR catalytic converter system which has a first SCR cat2020
Determining an ammonia mass flow between two SCR catalytic converters2019
Method for operating an SCR catalyic converter provided for the aftertreatment o2015
Polyol modified aminoglycoside-lipid conjugates2015
Hydrophobically enhanced aminoglycosides2014
Procedure for metering a reagent and device for implementing the procedure2013
Procedure for operating a combustion engine with a SCR-catalyzer2013